| human | Q5 |
| P496 | ORCID iD | 0000-0002-3049-1408 |
| P1153 | Scopus author ID | 9842954300 |
| P735 | given name | Carolina | Q5044762 |
| Carolina | Q5044762 | ||
| P106 | occupation | researcher | Q1650915 |
| Q37988609 | Breast cancer therapy based on melatonin. |
| Q48607770 | Complementary actions of melatonin on angiogenic factors, the angiopoietin/Tie2 axis and VEGF, in co‑cultures of human endothelial and breast cancer cells |
| Q96294382 | Editorial for the Special Issue "New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies" |
| Q40162331 | Effects of MT1 melatonin receptor overexpression on the aromatase-suppressive effect of melatonin in MCF-7 human breast cancer cells. |
| Q83220873 | Estrogen-signaling pathway: a link between breast cancer and melatonin oncostatic actions |
| Q46540764 | Exposure to light-at-night increases the growth of DMBA-induced mammary adenocarcinomas in rats. |
| Q43108453 | In vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin. |
| Q50802249 | Infinitesimal Hartman-Grobman Theorem in Dimension Three. |
| Q86448882 | Melatonin affects the dynamic steady-state equilibrium of estrogen sulfates in human umbilical vein endothelial cells by regulating the balance between estrogen sulfatase and sulfotransferase |
| Q47273940 | Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats. |
| Q98162610 | Melatonin as a Radio-Sensitizer in Cancer |
| Q37347106 | Melatonin as a selective estrogen enzyme modulator. |
| Q86549618 | Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis |
| Q47328763 | Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells. |
| Q40358739 | Melatonin enhances the inhibitory effect of aminoglutethimide on aromatase activity in MCF-7 human breast cancer cells. |
| Q38713812 | Melatonin inhibits angiogenesis in SH-SY5Y human neuroblastoma cells by downregulation of VEGF. |
| Q37424009 | Melatonin inhibits aromatase promoter expression by regulating cyclooxygenases expression and activity in breast cancer cells |
| Q40288398 | Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium. |
| Q46634464 | Melatonin inhibits the growth of DMBA-induced mammary tumors by decreasing the local biosynthesis of estrogens through the modulation of aromatase activity. |
| Q86232036 | Melatonin modulates aromatase activity and expression in endothelial cells |
| Q39946066 | Melatonin modulates the cadmium-induced expression of MT-2 and MT-1 metallothioneins in three lines of human tumor cells (MCF-7, MDA-MB-231 and HeLa). |
| Q33844198 | Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review). |
| Q51756711 | Melatonin prevents the estrogenic effects of sub-chronic administration of cadmium on mice mammary glands and uterus. |
| Q42808778 | Melatonin promotes differentiation of 3T3-L1 fibroblasts. |
| Q52972430 | Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair. |
| Q36090778 | Melatonin-estrogen interactions in breast cancer. |
| Q46197250 | The effect of estradiol, progesterone, and melatonin on estrous cycling and ovarian aromatase expression in intact female mice |
| Q33597963 | What is known about melatonin, chemotherapy and altered gene expression in breast cancer |
Search more.